Therapy Area
Allergy & Immunology
Cardiology
Dermatology
Diabetes
Flagship Journal
Gastroenterology
General Healthcare
Hematology
Hepatology
Innovations
Interventional Cardiology
Microbiology & Infectious Diseases
Nephrology
Neurology
Oncology
Radiology
Reproductive Health
Respiratory
Rheumatology
Urology
Podcasts
Journals
Webinars
Congress Hub
Toolkit
Paediatric Growth Calculator
DVT Risk Calculator
Due Date Calculator
Mean Arterial Pressure (MAP) Calculator
Collaborate
About
EQOH
Careers
Contact Us
Media Pack
Editorial Enquiries
Contributors & Authors
Submit a Paper
Media Partners
Pharma Partners
EMJ Interactive
EMJ GOLD
CME
search
Join
FREE
This site is intended for healthcare professionals
You must accept all conditions before being able to view the post
Continue
EUR
USA
EUR
USA
Therapy Area
Allergy & Immunology
Cardiology
Dermatology
Diabetes
Flagship Journal
Gastroenterology
General Healthcare
Hematology
Hepatology
Innovations
Interventional Cardiology
Microbiology & Infectious Diseases
Nephrology
Neurology
Oncology
Radiology
Reproductive Health
Respiratory
Rheumatology
Urology
Podcasts
Journals
Webinars
Congress Hub
Toolkit
Paediatric Growth Calculator
DVT Risk Calculator
Due Date Calculator
Mean Arterial Pressure (MAP) Calculator
Collaborate
About
EQOH
Careers
Contact Us
Media Pack
Editorial Enquiries
Contributors & Authors
Submit a Paper
Media Partners
Pharma Partners
EMJ Interactive
EMJ GOLD
CME
Join
FREE
Edition
European
US
Respiratory
Filter
Journals
About
Congress reviews
Abstracts
Articles
Podcasts
Videos & Webinars
News
Infographics
Submit A Paper
Rilzabrutinib Shows Promise in Uncontrolled Asthma
May 2026
Rilzabrutinib improved asthma control in patients with moderate-to-severe uncontrolled asthma in a phase 2 trial, highlighting a potential new treatment pathway.
Read more
24 May 2026
Rilzabrutinib Shows Promise in Uncontrolled Asthma
Rilzabrutinib improved asthma control in patients with moderate-to-severe uncontrolled asthma in a phase 2 trial, highlighting a potential new treatment pathway.
21 May 2026
Online Singing Programme Eases Long COVID Symptoms
ENO Breathe was associated with improved breathlessness, anxiety, respiratory symptoms, and health related quality of life in people with long COVID.
3 May 2026
Nebuliser Use Linked to Severe COPD
Nebuliser use in COPD is most common in severe disease with frequent exacerbations, high symptoms, and reduced lung function.
30 Apr 2026
Air Pollution Linked to Increased Respiratory Infections in Infants
New cohort data show higher air pollution exposure is linked to more respiratory infections and wheezing in infants during the first year of life.
19 Apr 2026
Inhaled Therapy Targets Lung Inflammation After Infection
A new inhaled therapy targeting lung inflammation shows promise in reducing damage and improving recovery after severe respiratory infections.
13 Apr 2026
Severe Asthma Multimorbidity Reveals Distinct Clinical Phenotypes
European data identify distinct multimorbidity patterns in severe asthma, linking comorbid clusters to outcomes, steroid use, and disease control.
12 Apr 2026
SPECT Scan May Support Pulmonary Embolism Diagnosis
SPECT lung scans show low clot risk at three months, suggesting a potential alternative to CT in pulmonary embolism diagnosis.
9 Apr 2026
AI Model Boosts Lung Cancer Detection Accuracy to 96%
A new hybrid AI model improves lung cancer detection on CT scans, achieving over 96% accuracy for early tumour identification.
Loading posts...
1
2
3
…
49
Next »
We’ve noticed you’re accessing
from
North/South America.
View
View